News

Evidenced-based dual diagnosis treatment facility, Chiron Recovery executed a MAT program for the treatment of opioid addiction. Addiction is a chronic disease and just like other…
Read More...

Global pharmaceutical company, Glenmark Pharmaceuticals ventured into an exclusive agreement with Sam Chun Dang Pharma. Co. Ltd. (SCD) to develop, manufacture and market a portfolio of…
Read More...

Dr. Warren Krackov, interventional radiologist specializing in minimally invasive treatment for dialysis access management and other vascular conditions has been named medical director…
Read More...

Medical device company, INVO Bioscience sought FDA clearance for Intravaginal Culture System, INVOcell asserted that Alabama Fertility has augmented its scope of reproductive treatments…
Read More...

Biotechnology company developing innovative products to fill women's unmet healthcare needs, Evofem Biosciences asserted that the U.S FDA has extended Fast Track designation for Amphora…
Read More...

GSK presented at the Center for Disease Control and Prevention Advisory Committee on Immunization Practices meeting that FLUARIX QUADRIVALENT exhibited 63.2% efficacy against moderate…
Read More...

Company dedicated to enhancing healthcare through earlier detection of cancer, Imagion Biosystems, asserted the appointment of Farideh Bischoff, PhD as the Vice President of Clinical…
Read More...

Wholly owned subsidiary of Teleflex, NeoTract emphasizing to address and resolve needs in the field of urology declared that the U.S Food and Drug Administration has sanctioned new…
Read More...

Nativis, a clinical-stage therapeutic device company developing non-sterile, non-invasive, non-thermal treatments for cancers and other grave diseases asserted that it has received a…
Read More...

Qiagen approved a decision by the U.S centers for Disease Control to use modern blood-based tests (IGRA) for tuberculosis (TB) screening. The CDC Division of Global Migration and…
Read More...

Rubius Therapeutics asserted the appointment of Spencer Fisk as Senior Vice-President, Manufacturing. Rubius Therapeutics is a biotechnology company endeavoring the creation of a new…
Read More...

Impax Laboratories asserted the roll out of generic version of Solodyn (minocycline HCl) extended-release tablets, 65 mg and 115 mg. Minocycline HCl extended-release tablets, 65 mg…
Read More...

Recovery Centers of America (RCA) asserted the appointment of Laura Ames as the Chief Executive Officer of Danvers facility. Laura Ames brings on board more than 20 years of experience…
Read More...

Mylan N.V, which is a global pharmaceutical company asserted receipt of tentative approval from the U.S Food and Drug Administration under the U.S President's Emergency Plan for AIDS…
Read More...

Achieve Life Sciences which is a clinical-stage pharmaceutical company devoted to the global development and commercialization of cytisine ensuring routing smoking or terminating…
Read More...

KAND567 is an orally available small molecule that blocks CX3CR1, the Fractalkine receptor. It is to be noted that Fractalkine receptor is an immunomodulating factor termed as …
Read More...

PTC Therapeutics asserted that the office of New Drugs of the U.S Food and Drug Administration has reaffirmed the FDA's former position quashing PTC's appeal of the Complete Response…
Read More...

Catheter Precision Inc. asserted the launch of a pivotal Clinical Trial to evaluate the safety and accuracy of the VIVO Non-Invasive Mapping system. The VIVO system is designed to…
Read More...

Alcyone Lifesciences, a company focused on transforming disease modifying therapies for central nervous system disorders asserted the demarcation of its Hydrocephalus business.…
Read More...

Micromedic Technologies declared successful results of a Clinical study designed to detect prostate cancer cells in urine specimens using its CellDetect technology. The study…
Read More...